45. Prognostic Determinants Associated with Efficacy of Adenoviral p53 Gene Therapy (Advexin) in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

doi:10.1016/s1525-0016(16)44251-6

45. Prognostic Determinants Associated with Efficacy of Adenoviral p53 Gene Therapy (Advexin) in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Open Access

https://doi.org/10.1016/s1525-0016(16)44251-6

Copy DOI

Journal: Molecular Therapy	Publication Date: May 1, 2007
License type: cc-by-nc-nd

#Squamous Cell Carcinoma Of The Head And Neck #Efficacy Of Gene Therapy + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

45. Prognostic Determinants Associated with Efficacy of Adenoviral p53 Gene Therapy (Advexin) in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Molecular Therapy

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.